News
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...
6d
Baller Alert on MSNOzempic and Zepbound Lawsuits Explode: Patients Say Popular Weight-Loss Drugs Left Them Hospitalized
More than 2,000 lawsuits are now targeting the makers of Ozempic and Zepbound, with patients claiming the drugs caused dangerous and sometimes permanent health problems. The cases, consolidated in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results